Log in

NASDAQ:CARACara Therapeutics Earnings Date, Estimates & History

$16.46
+0.53 (+3.33 %)
(As of 05/22/2020 04:00 PM ET)
Add
Compare
Today's Range
$15.69
Now: $16.46
$16.48
50-Day Range
$12.39
MA: $14.57
$16.17
52-Week Range
$8.88
Now: $16.46
$27.55
Volume538,707 shs
Average Volume581,899 shs
Market Capitalization$770.33 million
P/E RatioN/A
Dividend YieldN/A
Beta1.87

Earnings

Cara Therapeutics (NASDAQ:CARA) Earnings Information

Cara Therapeutics last released its quarterly earnings results on May 11th, 2020. The biopharmaceutical company reported ($0.62) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.63) by $0.01. The company earned $8.09 million during the quarter, compared to analysts' expectations of $4.83 million. Cara Therapeutics has generated ($2.49) earnings per share over the last year. Cara Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 5th, 2020 based off prior year's report dates.

Cara Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Cara Therapeutics (NASDAQ:CARA) Earnings Estimates

2020 EPS Consensus Estimate: ($2.59)
2021 EPS Consensus Estimate: ($2.75)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.64)($0.64)($0.64)
Q2 20202($0.67)($0.65)($0.66)
Q3 20203($0.67)($0.60)($0.63)
Q4 20203($0.67)($0.65)($0.66)
Q1 20212($0.80)($0.79)($0.80)
Q2 20212($0.82)($0.80)($0.81)
Q3 20212($0.69)($0.64)($0.67)
Q4 20211($0.48)($0.48)($0.48)

Cara Therapeutics (NASDAQ CARA) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/5/2020
(Estimated)
       
5/11/20203/31/2020($0.63)($0.62)($0.62)$4.83 million$8.09 millionTranscript
2/27/202012/31/2019($0.66)($0.61)($0.61)$5.58 million$4.51 millionTranscript
11/5/2019Q3($0.59)($0.74)($0.74)$5.56 million$5.79 millionTranscript
8/7/2019Q2 2019($0.61)($0.58)($0.58)$5.14 million$5.21 millionTranscript
5/7/20193/31/2019($0.55)($0.56)($0.56)$5.14 million$4.38 millionN/A
3/12/201912/31/2018($0.59)($0.52)($0.52)$3.35 million$5.53 millionTranscript
11/6/2018Q3($0.46)($0.51)($0.51)$4.72 million$5.06 millionTranscript
8/7/2018Q2 2018($0.50)($0.5160)($0.52)$0.63 million$2.87 millionN/A
5/9/2018Q1 2018($0.4740)($0.5130)($0.51)$0.19 millionN/A
3/15/2018Q4 2017($0.39)($0.43)($0.43)$0.11 millionTranscript
11/2/2017Q3 2017($0.35)($0.38)($0.38)$0.27 millionN/A
8/3/2017Q2 2017($0.61)($0.29)($0.29)$0.13 millionListen
5/4/2017Q1 2017($0.73)($0.81)($0.81)$0.11 million$0.91 millionListen
3/9/2017Q4 2016($0.53)($0.81)($0.81)N/A
11/3/2016Q3($0.47)($0.42)($0.42)$0.09 millionN/A
8/4/2016Q216($0.42)($0.48)($0.48)$0.13 million$0.08 millionN/A
5/5/2016Q116($0.40)($0.39)($0.39)$0.03 million$0.01 millionN/A
3/10/2016Q4($0.33)($0.35)($0.35)$0.53 millionListen
11/9/2015Q315($0.27)($0.19)($0.19)$1.86 million$2.40 millionN/A
8/10/2015Q215($0.24)($0.25)($0.25)$0.50 million$0.87 millionListen
5/12/2015Q415($0.22)($0.21)($0.21)$0.70 million$0.50 millionListen
3/26/2015Q4($0.28)($0.18)($0.18)$1.00 million$0.91 millionListen
11/10/2014Q314($0.22)($0.29)($0.29)$0.13 million$1.13 millionN/A
8/7/2014Q2($0.27)($0.16)($0.16)$0.08 million$0.96 millionN/A
5/12/2014Q1($0.14)($0.22)($0.22)$0.30 million$0.18 millionTranscript
3/27/2014Q4 2013($0.42)($0.49)($0.49)$0.90 million$0.97 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.